SAN DIEGO, CA --(Marketwired - September 13, 2016) - Medical Marijuana, Inc. (
"We're honored to have been part of the Howard family's journey and applaud Penny Howard's continued courage to share her daughter Harper's story, and continue her efforts to raise funds for critical medical research that will help other families around the world," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "As we've seen time and again in legalization efforts across the nation, families of young children with special needs are helping drive the conversation around cannabis reform by sharing their stories."
Hope4Harper was started by Penny Howard, a Dallas mom whose daughter Harper Elle Howard was born with a very rare, non-hereditary, life-threatening genetic disorder called CDKL5 epilepsy. The Howard family found out about HempMeds® Real Scientific Hemp Oil™ (RSHO™) after weeks and weeks of research online and Penny Howard later became a spokesperson for HempMeds® of her own volition.
Sadly, Harper Howard passed away on Jan. 8, 2016, due to additional medical complications beyond CDKL5, however Harper's bold spirit lives on through the family's decision to donate her 28-month daily cannabidiol (CBD) hemp oil brain and a deep tissue sample to medical research. Harper was the first-ever brain and deep tissue sample donated to CDKL5 research in world history.
Harper Howard's donation is already having a profound impact on medical research for a wide range of neurological conditions under the guidance of University of California San Diego School of Medicine's lead stem cell researcher, Dr. Alysson Muotri.
In addition, by posting the progress of her daughter Harper's journey on Hope4Harper's Facebook blog , she became the catalyst for the historic decision by Brazil's government to import Medical Marijuana, Inc.'s RSHO™ -- and subsidize payments for RSHO™ under the Brazilian government's health care system.
On-site registration for the Run4Hope will begin at 7 a.m., the fun run will commence at 7:30 a.m., and the 5K will start at 8:00 a.m. Registration fees range from $25 to $40 per person. Proceeds will benefit much-needed research on rare genetic disorder CDKL5 and to support studies by Frances Jensen, M.D, epileptologist at the University of Pennsylvania, and Alysson Muotri, Ph.D., stem cell neuroscientist at the University of California, San Diego, where Harper's deep tissue donation currently lives.
For more information on Hope4Harpr and the Run4Hope visit here. For more information on HempMeds® visit https://hempmedspx.com .
About HempMeds® HempMeds ® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds ® is a corporate portfolio company of Medical Marijuana, Inc. (
About Medical Marijuana, Inc. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com .
To see Medical Marijuana, Inc.'s video statement, click here . Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 888-829- 0070 andrew.hard@cmwmedia.com www.cmwmedia.com Corporate Business Contact: Nicholas R. Massalas Director of Business Development Medical Marijuana, Inc. OTC Symbol: MJNA Toll Free: 888-OTC- MJNA (888-682- 6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations Contact: EquiNet, LLC Toll Free: (877) 964.6463 Office/Direct: (858) 264-6500 Email: info@equinet.us www.equinet.us
